Raiffeisen Bank International AG
BankPosition in TEVA — Teva Pharmaceutical Industries Ltd
CIK 2044885
VIENNA, C4
Position in TEVA
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,632,202
+$673,061 QoQ
Shares Held
48,176
+51.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#284
of 671 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Derivatives in TEVA
reported options exposure · as of Jun 30, 2026CallValue
$276,731
CallShares
8,168
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Raiffeisen Bank International AG holds $7,748,668 across 4 Drug Manufacturers - Specialty & Generic names. TEVA ranks #3 (21.1% of the industry book) .
All Filings in TEVA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $276,731 | 8,168 | Call | Sole | 2026-08-03 | |
| 2026-06-30 | $1,632,202 | 48,176 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $959,141 | 31,844 | Shares | Sole | 2026-04-24 | |
| 2026-03-31 | $246,020 | 8,168 | Call | Sole | 2026-04-24 | |
| 2025-12-31 | $254,923 | 8,168 | Call | Sole | 2026-02-12 | |
| 2025-09-30 | $164,993 | 8,168 | Call | Sole | 2025-11-10 | |
| 2025-06-30 | $136,895 | 8,168 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $125,542 | 8,168 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $180,022 | 8,168 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||